Showing results (1921-1930 of 2,466) with videos related to
Sort By:
Pageof 247
Breast (Edinburgh, Scotland)|January 21, 2004
Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifenM Freue, M Kjaer, C Boni, et al.Endocrine-Related Cancer|September 7, 2006
Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progressionN Sarwar, J-S Kim, J Jiang, et al.Breast Cancer Research and Treatment|January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 26, 2020
An engaged approach to exploring issues around poverty and mental health: A reflective evaluation of the research process from researchers and community partners involved in the DeStress studyFelicity Thomas, Lorraine Hansford, Katrina Wyatt, et al.Plos One|March 30, 2011
Salmonella phage ST64B encodes a member of the SseK/NleB effector familyNat F Brown, Brian K Coombes, Jenna L Bishop, et al.Kidney & Blood Pressure Research|April 21, 2007
Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney diseaseJacqueline K Phillips, Deborah Hopwood, Rhonda A Loxley, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 9, 2020
Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized TrialJoyce S Ramos, Lance C Dalleck, Rebecca C Stennett, et al.The Journal of Endocrinology|April 17, 2003
Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cellsC Palmieri, D Roberts-Clark, A Assadi-Sabet, et al.Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.Oral Oncology|September 19, 2006
Molecular analysis of anoikis resistance in oral cavity squamous cell carcinomaMichael E Kupferman, Vyomesh Patel, Virote Sriuranpong, et al.Pageof 247